Table 1.
Bactericidal activity and cell-inactivation effect at bio-interface of graphene-derived materials.
graphene-based nanomaterial | bacteria | indicative antibacterial activitya | cell-inactivation effect | source |
---|---|---|---|---|
graphene and graphene oxide nanowalls | E. coli | 59% | cell membrane damage | [10] |
S. aureus | 84% | |||
graphene oxide nanosheets and reduced graphene oxide |
E. coli | 98.5% | loss of cellular integrity | [9] |
graphene oxide nanosheets | E. coli | 89% | ROS-independent oxidative stress | [8] |
graphene oxide fabric | E. coli | 98% | cell membrane damage | [12] |
PVK–graphene nanocomposite | E. coli | 91% | direct contact | [13] |
B. subtilis | 98% | |||
graphene oxide and reduced graphene oxide | P. aeruginosa | 87% | loss of cell viability due to oxidative stress and DNA fragmentation | [14] |
graphene oxide films | E. coli | 89% | suggested that the edges of GO are not an integral part of its antimicrobial mechanism | [15] |
graphene oxide nanosheet | E. coli | 97.7% | ‘wrapping’ effect of large GO nanosheets removing bacteria from access to available nutrients | [16] |
aAntibacterial efficacy should be regarded as indicative only as different protocols are used in different laboratories.